APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Beraprost Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Beraprost Sodium Market Outlook and Growth Opportunities 2026

Report ID 173969870420 December 2025201 pages

Choose your research edition.

Industry ResearchBeraprost Sodium Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Beraprost Sodium Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Beraprost Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beraprost Sodium Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Beraprost Sodium Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Beraprost Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beraprost Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Beraprost Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Beraprost Sodium market include Teva, Daiichi Sankyo Co Ltd, Yoshindo, Viatris, Toray, Taide Pharma, Shin Poong Pharmaceutical, Sawai Pharmaceutical and Ohara Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Beraprost Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beraprost Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beraprost Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beraprost Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Beraprost Sodium Segment by Company

Teva

Daiichi Sankyo Co Ltd

Yoshindo

Viatris

Toray

Taide Pharma

Shin Poong Pharmaceutical

Sawai Pharmaceutical

Ohara Inc

Nihon Generic Co Ltd

Nichiiko

NABIQASIM INDUSTRIES

Lupin Laboratories

KYOUSOUMIRAI PHARM

Kyorin Holding

Kaken Pharmaceutical

Astellas Pharma

Alfresa Pharma

Beraprost Sodium Segment by Type

Tablet

Sustained Release Tablets

Beraprost Sodium Segment by Application

Hospital

Clinic

Beraprost Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Beraprost Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Beraprost Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Beraprost Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Beraprost Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beraprost Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beraprost Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beraprost Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Beraprost Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Beraprost Sodium industry.

Chapter 3: Detailed analysis of Beraprost Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Beraprost Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Beraprost Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Beraprost Sodium Industry Trends Table 2. Beraprost Sodium Industry Drivers Table 3. Beraprost Sodium Industry Opportunities and Challenges Table 4. Beraprost Sodium Industry Restraints Table 5. Global Beraprost Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Beraprost Sodium Revenue Share by Company (2021-2026) Table 7. Global Beraprost Sodium Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Beraprost Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Beraprost Sodium Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Beraprost Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Beraprost Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Beraprost Sodium Company, Product Type & Application Table 13. Global Beraprost Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Beraprost Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablet Table 18. Significant Companies of Sustained Release Tablets Table 19. Global Beraprost Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 20. Global Beraprost Sodium Sales Volume by Type (2021-2026) & (k pcs) Table 21. Global Beraprost Sodium Sales Volume by Type (2027-2032) & (k pcs) Table 22. Global Beraprost Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Beraprost Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Beraprost Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Beraprost Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Beraprost Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Beraprost Sodium Sales Value Share by Type (2021-2026) Table 28. Global Beraprost Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Beraprost Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 32. Global Beraprost Sodium Sales Volume by Application (2021-2026) & (k pcs) Table 33. Global Beraprost Sodium Sales Volume by Application (2027-2032) & (k pcs) Table 34. Global Beraprost Sodium Sales Volume Share by Application (2021-2026) Table 35. Global Beraprost Sodium Sales Volume Share by Application (2027-2032) Table 36. Global Beraprost Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Beraprost Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Beraprost Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Beraprost Sodium Sales Value Share by Application (2021-2026) Table 40. Global Beraprost Sodium Sales Value Share by Application (2027-2032) Table 41. Global Beraprost Sodium Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 42. Global Beraprost Sodium Sales by Region (2021-2026) & (k pcs) Table 43. Global Beraprost Sodium Sales Market Share by Region (2021-2026) Table 44. Global Beraprost Sodium Sales by Region (2027-2032) & (k pcs) Table 45. Global Beraprost Sodium Sales Market Share by Region (2027-2032) Table 46. Global Beraprost Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Beraprost Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Beraprost Sodium Sales Value Share by Region (2021-2026) Table 49. Global Beraprost Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Beraprost Sodium Sales Value Share by Region (2027-2032) Table 51. Global Beraprost Sodium Market Average Price (US$/pcs) by Region (2021-2026) Table 52. Global Beraprost Sodium Market Average Price (US$/pcs) by Region (2027-2032) Table 53. Global Beraprost Sodium Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 54. Global Beraprost Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Beraprost Sodium Sales by Country (2021-2026) & (k pcs) Table 56. Global Beraprost Sodium Sales Market Share by Country (2021-2026) Table 57. Global Beraprost Sodium Sales by Country (2027-2032) & (k pcs) Table 58. Global Beraprost Sodium Sales Market Share by Country (2027-2032) Table 59. Global Beraprost Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Beraprost Sodium Sales Value Market Share by Country (2021-2026) Table 61. Global Beraprost Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Beraprost Sodium Sales Value Market Share by Country (2027-2032) Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Teva Beraprost Sodium Product Portfolio Table 67. Teva Recent Development Table 68. Daiichi Sankyo Co Ltd Company Information Table 69. Daiichi Sankyo Co Ltd Business Overview Table 70. Daiichi Sankyo Co Ltd Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 71. Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio Table 72. Daiichi Sankyo Co Ltd Recent Development Table 73. Yoshindo Company Information Table 74. Yoshindo Business Overview Table 75. Yoshindo Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 76. Yoshindo Beraprost Sodium Product Portfolio Table 77. Yoshindo Recent Development Table 78. Viatris Company Information Table 79. Viatris Business Overview Table 80. Viatris Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 81. Viatris Beraprost Sodium Product Portfolio Table 82. Viatris Recent Development Table 83. Toray Company Information Table 84. Toray Business Overview Table 85. Toray Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 86. Toray Beraprost Sodium Product Portfolio Table 87. Toray Recent Development Table 88. Taide Pharma Company Information Table 89. Taide Pharma Business Overview Table 90. Taide Pharma Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 91. Taide Pharma Beraprost Sodium Product Portfolio Table 92. Taide Pharma Recent Development Table 93. Shin Poong Pharmaceutical Company Information Table 94. Shin Poong Pharmaceutical Business Overview Table 95. Shin Poong Pharmaceutical Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 96. Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio Table 97. Shin Poong Pharmaceutical Recent Development Table 98. Sawai Pharmaceutical Company Information Table 99. Sawai Pharmaceutical Business Overview Table 100. Sawai Pharmaceutical Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 101. Sawai Pharmaceutical Beraprost Sodium Product Portfolio Table 102. Sawai Pharmaceutical Recent Development Table 103. Ohara Inc Company Information Table 104. Ohara Inc Business Overview Table 105. Ohara Inc Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 106. Ohara Inc Beraprost Sodium Product Portfolio Table 107. Ohara Inc Recent Development Table 108. Nihon Generic Co Ltd Company Information Table 109. Nihon Generic Co Ltd Business Overview Table 110. Nihon Generic Co Ltd Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 111. Nihon Generic Co Ltd Beraprost Sodium Product Portfolio Table 112. Nihon Generic Co Ltd Recent Development Table 113. Nichiiko Company Information Table 114. Nichiiko Business Overview Table 115. Nichiiko Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 116. Nichiiko Beraprost Sodium Product Portfolio Table 117. Nichiiko Recent Development Table 118. NABIQASIM INDUSTRIES Company Information Table 119. NABIQASIM INDUSTRIES Business Overview Table 120. NABIQASIM INDUSTRIES Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 121. NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio Table 122. NABIQASIM INDUSTRIES Recent Development Table 123. Lupin Laboratories Company Information Table 124. Lupin Laboratories Business Overview Table 125. Lupin Laboratories Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 126. Lupin Laboratories Beraprost Sodium Product Portfolio Table 127. Lupin Laboratories Recent Development Table 128. KYOUSOUMIRAI PHARM Company Information Table 129. KYOUSOUMIRAI PHARM Business Overview Table 130. KYOUSOUMIRAI PHARM Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 131. KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio Table 132. KYOUSOUMIRAI PHARM Recent Development Table 133. Kyorin Holding Company Information Table 134. Kyorin Holding Business Overview Table 135. Kyorin Holding Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 136. Kyorin Holding Beraprost Sodium Product Portfolio Table 137. Kyorin Holding Recent Development Table 138. Kaken Pharmaceutical Company Information Table 139. Kaken Pharmaceutical Business Overview Table 140. Kaken Pharmaceutical Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 141. Kaken Pharmaceutical Beraprost Sodium Product Portfolio Table 142. Kaken Pharmaceutical Recent Development Table 143. Astellas Pharma Company Information Table 144. Astellas Pharma Business Overview Table 145. Astellas Pharma Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 146. Astellas Pharma Beraprost Sodium Product Portfolio Table 147. Astellas Pharma Recent Development Table 148. Alfresa Pharma Company Information Table 149. Alfresa Pharma Business Overview Table 150. Alfresa Pharma Beraprost Sodium Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 151. Alfresa Pharma Beraprost Sodium Product Portfolio Table 152. Alfresa Pharma Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Beraprost Sodium Distributors List Table 156. Beraprost Sodium Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Beraprost Sodium Product Image Figure 2. Global Beraprost Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Beraprost Sodium Sales (2021-2032) & (k pcs) Figure 5. Global Beraprost Sodium Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Beraprost Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablet Image Figure 10. Sustained Release Tablets Image Figure 11. Global Beraprost Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 12. Global Beraprost Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Beraprost Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Beraprost Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Beraprost Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Beraprost Sodium Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Beraprost Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 20. Global Beraprost Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Beraprost Sodium Sales Volume Share by Application (2021-2032) Figure 22. Global Beraprost Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Beraprost Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Beraprost Sodium Sales Value Share by Application (2021-2032) Figure 25. Global Beraprost Sodium Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 26. Global Beraprost Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Beraprost Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Beraprost Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 30. North America Beraprost Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Beraprost Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Beraprost Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 36. South America Beraprost Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Beraprost Sodium Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Beraprost Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Beraprost Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Beraprost Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Beraprost Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Beraprost Sodium Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Beraprost Sodium Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Sustained Release Tablets
Applications
  • Hospital
  • Clinic
Companies covered
  • Teva
  • Daiichi Sankyo Co Ltd
  • Yoshindo
  • Viatris
  • Toray
  • Taide Pharma
  • Shin Poong Pharmaceutical
  • Sawai Pharmaceutical
  • Ohara Inc
  • Nihon Generic Co Ltd
  • Nichiiko
  • NABIQASIM INDUSTRIES
  • Lupin Laboratories
  • KYOUSOUMIRAI PHARM
  • Kyorin Holding
  • Kaken Pharmaceutical
  • Astellas Pharma
  • Alfresa Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Beraprost Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Beraprost Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Beraprost Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Beraprost Sodium Market Dynamics
  1. 2.1 Beraprost Sodium Industry Trends
  2. 2.2 Beraprost Sodium Industry Drivers
  3. 2.3 Beraprost Sodium Industry Opportunities and Challenges
  4. 2.4 Beraprost Sodium Industry Restraints
3 Beraprost Sodium Market by Company
  1. 3.1 Global Beraprost Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Beraprost Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Beraprost Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Beraprost Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Beraprost Sodium Company Ranking (2024-2026)
  6. 3.6 Global Beraprost Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Beraprost Sodium Company Product Type and Application
  8. 3.8 Global Beraprost Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Beraprost Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Beraprost Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Beraprost Sodium Market by Type
  1. 4.1 Beraprost Sodium Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Sustained Release Tablets
  4. 4.2 Global Beraprost Sodium Sales Volume by Type
  5. 4.2.1 Global Beraprost Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Beraprost Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Beraprost Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Beraprost Sodium Sales Value by Type
  9. 4.3.1 Global Beraprost Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Beraprost Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Beraprost Sodium Sales Value Share by Type (2021-2032)
5 Beraprost Sodium Market by Application
  1. 5.1 Beraprost Sodium Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Beraprost Sodium Sales Volume by Application
  5. 5.2.1 Global Beraprost Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Beraprost Sodium Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Beraprost Sodium Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Beraprost Sodium Sales Value by Application
  9. 5.3.1 Global Beraprost Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Beraprost Sodium Sales Value by Application (2021-2032)
  11. 5.3.3 Global Beraprost Sodium Sales Value Share by Application (2021-2032)
6 Beraprost Sodium Regional Sales and Value Analysis
  1. 6.1 Global Beraprost Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Beraprost Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Beraprost Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Beraprost Sodium Sales by Region (2027-2032)
  5. 6.3 Global Beraprost Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Beraprost Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Beraprost Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Beraprost Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Beraprost Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Beraprost Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Beraprost Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Beraprost Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Beraprost Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Beraprost Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Beraprost Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Beraprost Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Beraprost Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Beraprost Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Beraprost Sodium Sales Value Share by Country, 2025 VS 2032
7 Beraprost Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Beraprost Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Beraprost Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Beraprost Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Beraprost Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Beraprost Sodium Sales by Country (2027-2032)
  6. 7.4 Global Beraprost Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Beraprost Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Beraprost Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Beraprost Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Beraprost Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Beraprost Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Beraprost Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Beraprost Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Beraprost Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Beraprost Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Beraprost Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Beraprost Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Beraprost Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Beraprost Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Beraprost Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Beraprost Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Beraprost Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Beraprost Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Beraprost Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Beraprost Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Beraprost Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Beraprost Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Beraprost Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Beraprost Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Beraprost Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Beraprost Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Beraprost Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Beraprost Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Beraprost Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Beraprost Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Beraprost Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Beraprost Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Beraprost Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Beraprost Sodium Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Daiichi Sankyo Co Ltd
  8. 8.2.1 Daiichi Sankyo Co Ltd Company Information
  9. 8.2.2 Daiichi Sankyo Co Ltd Business Overview
  10. 8.2.3 Daiichi Sankyo Co Ltd Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Daiichi Sankyo Co Ltd Beraprost Sodium Product Portfolio
  12. 8.2.5 Daiichi Sankyo Co Ltd Recent Developments
  13. 8.3 Yoshindo
  14. 8.3.1 Yoshindo Company Information
  15. 8.3.2 Yoshindo Business Overview
  16. 8.3.3 Yoshindo Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yoshindo Beraprost Sodium Product Portfolio
  18. 8.3.5 Yoshindo Recent Developments
  19. 8.4 Viatris
  20. 8.4.1 Viatris Company Information
  21. 8.4.2 Viatris Business Overview
  22. 8.4.3 Viatris Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Viatris Beraprost Sodium Product Portfolio
  24. 8.4.5 Viatris Recent Developments
  25. 8.5 Toray
  26. 8.5.1 Toray Company Information
  27. 8.5.2 Toray Business Overview
  28. 8.5.3 Toray Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Toray Beraprost Sodium Product Portfolio
  30. 8.5.5 Toray Recent Developments
  31. 8.6 Taide Pharma
  32. 8.6.1 Taide Pharma Company Information
  33. 8.6.2 Taide Pharma Business Overview
  34. 8.6.3 Taide Pharma Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taide Pharma Beraprost Sodium Product Portfolio
  36. 8.6.5 Taide Pharma Recent Developments
  37. 8.7 Shin Poong Pharmaceutical
  38. 8.7.1 Shin Poong Pharmaceutical Company Information
  39. 8.7.2 Shin Poong Pharmaceutical Business Overview
  40. 8.7.3 Shin Poong Pharmaceutical Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shin Poong Pharmaceutical Beraprost Sodium Product Portfolio
  42. 8.7.5 Shin Poong Pharmaceutical Recent Developments
  43. 8.8 Sawai Pharmaceutical
  44. 8.8.1 Sawai Pharmaceutical Company Information
  45. 8.8.2 Sawai Pharmaceutical Business Overview
  46. 8.8.3 Sawai Pharmaceutical Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sawai Pharmaceutical Beraprost Sodium Product Portfolio
  48. 8.8.5 Sawai Pharmaceutical Recent Developments
  49. 8.9 Ohara Inc
  50. 8.9.1 Ohara Inc Company Information
  51. 8.9.2 Ohara Inc Business Overview
  52. 8.9.3 Ohara Inc Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Ohara Inc Beraprost Sodium Product Portfolio
  54. 8.9.5 Ohara Inc Recent Developments
  55. 8.10 Nihon Generic Co Ltd
  56. 8.10.1 Nihon Generic Co Ltd Company Information
  57. 8.10.2 Nihon Generic Co Ltd Business Overview
  58. 8.10.3 Nihon Generic Co Ltd Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nihon Generic Co Ltd Beraprost Sodium Product Portfolio
  60. 8.10.5 Nihon Generic Co Ltd Recent Developments
  61. 8.11 Nichiiko
  62. 8.11.1 Nichiiko Company Information
  63. 8.11.2 Nichiiko Business Overview
  64. 8.11.3 Nichiiko Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Nichiiko Beraprost Sodium Product Portfolio
  66. 8.11.5 Nichiiko Recent Developments
  67. 8.12 NABIQASIM INDUSTRIES
  68. 8.12.1 NABIQASIM INDUSTRIES Company Information
  69. 8.12.2 NABIQASIM INDUSTRIES Business Overview
  70. 8.12.3 NABIQASIM INDUSTRIES Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 NABIQASIM INDUSTRIES Beraprost Sodium Product Portfolio
  72. 8.12.5 NABIQASIM INDUSTRIES Recent Developments
  73. 8.13 Lupin Laboratories
  74. 8.13.1 Lupin Laboratories Company Information
  75. 8.13.2 Lupin Laboratories Business Overview
  76. 8.13.3 Lupin Laboratories Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lupin Laboratories Beraprost Sodium Product Portfolio
  78. 8.13.5 Lupin Laboratories Recent Developments
  79. 8.14 KYOUSOUMIRAI PHARM
  80. 8.14.1 KYOUSOUMIRAI PHARM Company Information
  81. 8.14.2 KYOUSOUMIRAI PHARM Business Overview
  82. 8.14.3 KYOUSOUMIRAI PHARM Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 KYOUSOUMIRAI PHARM Beraprost Sodium Product Portfolio
  84. 8.14.5 KYOUSOUMIRAI PHARM Recent Developments
  85. 8.15 Kyorin Holding
  86. 8.15.1 Kyorin Holding Company Information
  87. 8.15.2 Kyorin Holding Business Overview
  88. 8.15.3 Kyorin Holding Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Kyorin Holding Beraprost Sodium Product Portfolio
  90. 8.15.5 Kyorin Holding Recent Developments
  91. 8.16 Kaken Pharmaceutical
  92. 8.16.1 Kaken Pharmaceutical Company Information
  93. 8.16.2 Kaken Pharmaceutical Business Overview
  94. 8.16.3 Kaken Pharmaceutical Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Kaken Pharmaceutical Beraprost Sodium Product Portfolio
  96. 8.16.5 Kaken Pharmaceutical Recent Developments
  97. 8.17 Astellas Pharma
  98. 8.17.1 Astellas Pharma Company Information
  99. 8.17.2 Astellas Pharma Business Overview
  100. 8.17.3 Astellas Pharma Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Astellas Pharma Beraprost Sodium Product Portfolio
  102. 8.17.5 Astellas Pharma Recent Developments
  103. 8.18 Alfresa Pharma
  104. 8.18.1 Alfresa Pharma Company Information
  105. 8.18.2 Alfresa Pharma Business Overview
  106. 8.18.3 Alfresa Pharma Beraprost Sodium Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Alfresa Pharma Beraprost Sodium Product Portfolio
  108. 8.18.5 Alfresa Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Beraprost Sodium Value Chain Analysis
  2. 9.1.1 Beraprost Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Beraprost Sodium Sales Mode & Process
  6. 9.2 Beraprost Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Beraprost Sodium Distributors
  9. 9.2.3 Beraprost Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst